24/7 Customer Service (800) 927-7671

Stock Update (NASDAQ:AMDA): Amedica Corporation First to 3D Print Silicon Nitride for Medical Applications – Smarter Analyst

by • March 22, 2016 • No Comments

Amedica Corporation (NASDAQ:AMDA), a company which creates and commercializes silicon nitride ceramics as a biomaterial platform, is cheerful to announce its initially fabrication of harsh, three-dimensional structures by a 3D printing system called robotic deposition, or robocasting. The final products have been examined under scanning electron microscopy to confirm the integrity and validity of the 3D printing method, and have been shown to complete much like theoretical density and microstructure attributes to the traditionally maked silicon nitride fusion devices already in use.
“This innovation speaks to the one-of-a-kind art and science related to our making strength,” said Dr. Sonny Bal, Chairman and Chief Executive Officer. “3D printing of a harsh ceramic material opens next doors, especially in terms of cost advantages, and addressing a variety of OEM partner needs. Custom additive making is a modern innovation, and we are proud to lead the way in 3D printing of our silicon nitride formulation, with its advantages in bone fusion, antibacterial behavior, and excellent strength.”
Robocasting is a freeform fabrication technique for dense ceramics and composites which is based on layered deposition of highly colloidal slurries. The system is fundamentally binder-less and a device can be completely sintered in less than 24 hours. With this innovation, Amedica can now progress in the direction of commercializing 3D printed silicon nitride implants, with controllable porosity levels to address specific clinical needs. This one-of-a-kind making method is promising for the production of anatomically relevant shaped silicon nitride implants, while in addition enabling custom fabrication of bone scaffolds suited for cellular differentiation and neovascularization. (Original Source)
Shares of Amedica Corp. closed yesterday at $1.65, down $-0.20 or -10.81%. AMDA has a 1-year high of $12.59 and a 1-year low of $1.16. The stock’s 50-day moving average is $2.34 and its 200-day moving average is $2.97.
Amedica Corp s a commercial-stage biomaterial company. It is engaged in via its silicon nitride innovation platform to create, make & commercialize medical devices. Its products include valeo interbody fusion devices & facet fixation.


Latest posts
test

by admin • March 5, 2017